Studies have investigated whether certain genetic alterations in Glutathione S-transferases (GSTs)—GSTP1, GSTM1, and GSTT1—that play a role in carcinogen metabolism and defense against reactive oxygen species are linked to prostate cancer risk. This evidence concerns the gene HPGDS and prostate cancer.